Tramadol Use and Dependence in Chronic Noncancer Pain Patients

Over a two year period, we have seen 20 cases with physical dependence of tramadol, 17 of them had initially received tramadol for chronic noncancer pain. Clinical characteristics of these patients are given. Twelve of them (60 %) did not complete detoxification, indicating this to be a difficult patient group.

References

• 1 Brinker A, Bonnel R A, Beitz J. Abuse, dependence, withdrawal associated with tramadol (letter).  Am J Psychiatry. 2002;  159 881
• 2 Cicero T J, Adams E H, Giller H, Inciardi J A, Monoz A, Schnoll S H, Senay E Z, Woody G E. A post marketing surveillance programme to monitor ultram (tramadol hydrochloride) abuse in the United States.  Drug Alcohol Depend. 1999;  57 7-22
• 3 Dertwinkel R, Wiebalck A, Zenz M, Strumpf M. Oral opioids for long-term treatment of chronic non-cancer pain (in German).  Anaesthesist. 1996;  45 495-505
• 4 Dunbar S A, Katz N P. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases.  J Pain Symptom Manag. 1996;  11 163-171
• 5 Gostomzyk J G, Heller W -D. Long-term use of narcotics in pain (in German).  Dtsch Med Wochenschr. 1990;  115 763-770
• 6 Grond S, Meuser T, Zech D, Henning U, Lehmann K A. Analgesic efficacy and safety of tramadol enentiomers in comparison with racemate: a randomised, double-blind study with gynecological patients using intravenous patient-controlled analgesia.  Pain. 1995;  62 313-320
• 7 Joranson D E, Ryan K M, Gilson A M, Dahl J P. Trends in medical use and abuse of opioid analgesics.  JAMA. 2000;  283 1710-1714
• 8 Kanner R. Opioids for chronic pain: issues is efficacy, not addiction.  Neurol Net Commun. 1998;  2 175-179
• 9 Keup W. Mißbrauchsmuster 1998. Frühwarnsystem-Daten für die Bundesrepublik Deutschland 1976-1998. Starnberg; 1999
• 10 Kouynaou K, Pither C E, Rabe-Hesketh S, Wessely S. A comparative study of Iatrogenesis, medication abuse and psychiatric morbidity in chronic pain patients with and without medically explained symptoms.  Pain. 1998;  76 417-426
• 11 Kouyanou K, Pither C E, Wesseley S. Medication misues, abuse and dependence in chronic pain patients.  J Psychosom Res. 1997;  43 497-504
• 12 Lee C R, McTavish D, Sorkin E M. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.  Drugs. 1993;  46 313-340
• 13 Leo R J, Narendan R, DeGuiseppe B. Methadone detoxification of tramadol dependence.  J Subst Abuse Treat. 2000;  19 297-299
• 14 Phillipp M, Fickinger M. Psychotropic drugs in the management of chronic pain syndromes.  Pharmacopsychiatry. 1993;  26 221-234
• 15 Preston K L, Jasinski R D, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine.  Drug Alcohol Depend. 1991;  27 7-17
• 16 Porter J, Jick H. Addiction rare in patients treated with narcotics.  N Engl J Med. 1980;  302 123-125
• 17 Protenoy R K, Foley K M. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases.  Pain. 1986;  25 171-186
• 18 Quang-Cantagrel N D, Wallace M S, Manuson S K. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review.  Anesth Analg. 2000;  90 933-937
• 19 Radbruch L, Grond S, Lehmann K A. A risk benefit assessment of tramadol in the management of pain.  Drug Saf. 1996;  15 8-29
• 20 Roider G, Drasch G, v Meyer L, Sachs H. Tramadol als Drogenersatz.  DAZ. 2000;  140 3373-3375
• 21 Russel K, Portenoy M D. Opioid therapy for nonmalignant pain: a review of the critical issues.  J Pain Symptom Manag. 1996;  11 203-217
• 22 Schmidt-Kittler H, v Meyer L. Drogenbedingte Todesfälle 1998. Suchtmed 2000: 103-109
• 23 Wambach S, Rohr P, Häuser W. Abuse of opioid therapie in somatoform pain disorder. A contribution from a psychosomatic/ pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases (in German).  Schmerz. 2001;  15 254-264
• 24 Yates W R, Nguyen M H, Warnock Y K. Tramadol dependence with no history of substance abuse.  Am J Psychiatry. 2001;  158 964